Edgewise Therapeutics CMO Joanne M. Donovan disposes of USD 411,192 in common shares - EWTX News | RalliesEdgewise Therapeutics CMO Joanne M. Donovan disposes of USD 411,192 in common shares
E
EWTX• Insider transaction details
- Edgewise Therapeutics CMO Joanne M. Donovan reported RSU vesting on Aug. 12, 2026, adding 12,812 common shares.
- Sold 6,522 common shares on Aug. 12-13 at average prices of $43.41-$44.52.
- Directly owned 8,625 common shares following the transactions.
- Reported new equity awards on Aug. 12, 2026, including 32,500 restricted stock units and options covering 65,000 shares.
